Blog highlights factors potentially affecting U.S. support for global AIDS response in 2013

NewsGuard 100/100 Score

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Jenny Ottenhoff, policy outreach associate at the center, says "four big issues will impact U.S. support for the global response to the [AIDS] epidemic over the coming year." According to Ottenhoff, these issues include the FY 2013 budget; the upcoming presidential election; "looming, automatic, across-the-board spending cuts that will be triggered under sequestration in January 2013"; and the potential reauthorization of PEPFAR, which will be decided in 2013. "These storm clouds over AIDS funding could turn out to have a silver lining if austerity creates pressures to improve the global response to AIDS in ways that make it more effective and efficient," she writes (7/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing